NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000045563

Registered date:24/09/2021

Web-survey for atopic dermatitis control in Japan

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedAtopic dermatitis
Date of first enrollment2021/09/24
Target sample size6200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeCorrelation coefficient between the ADCT score and each of the four following scores (DLQI/POEM/Worst Itch-NRS (WI-NRS)/GQ)
Secondary Outcome-ADCT scores overall and by demographic characteristics (demographic characteristics: Age, gender, occupation, annual income, household composition, area of residence, and lifestyle) -Demographic characteristics by dupilumab users and non-users -Dosing patterns of dupilumab users (how long administered, whether or not they have ever discontinued it, length of temporary discontinuations) -ADCT and four (DLQI/POEM/WI-NRS/GQ) scores among dupilumab users and non-users

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria-Applicable to inappropriate responses

Related Information

Contact

public contact
Name Tomoyuki Kusaka
Address NMF Shinjuku East Bldg. 10-5 Tomihisacho, Shinjuku-ku, Tokyo 162-0067 JAPAN Japan 162-0067
Telephone 03-6709-9710
E-mail HOR@ssri.com
Affiliation Social Survey Research Information Co., Ltd. Healthcare BI & MA Service Division Health Outcomes Research
scientific contact
Name Tomoyuki Kusaka
Address NMF Shinjuku East Bldg. 10-5 Tomihisacho, Shinjuku-ku, Tokyo 162-0067 JAPAN Japan
Telephone 03-6709-9710
E-mail tkusaka@ssri.com
Affiliation Social Survey Research Information Co., Ltd. Healthcare BI & MA Service Division Health Outcomes Research